Clinical Trial Results:
A multi-center, randomized, double-blind, placebo and active controlled, parallel group, dose finding study to evaluate the efficacy and safety of LCI699 compared to placebo after 8 weeks treatment in patients with essential hypertension
Summary
|
|
EudraCT number |
2008-003139-19 |
Trial protocol |
FR SE NL DE |
Global completion date |
02 Jul 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v2(current) |
This version publication date |
29 Sep 2021
|
First version publication date |
12 Oct 2016
|
Other versions |
v1 |
Version creation reason |
|
Summary report(s) |
CLCI699A2201_NovCTR full results |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.